98%
921
2 minutes
20
Background: Many Asian countries have yet to scale up HIV pre-exposure prophylaxis (PrEP). Crowdsourcing has a group of individuals solving a specific problem before sharing solutions with the public. This approach enhances community engagement and ownership of the solutions and can be used to generate culturally relevant solutions. We used crowdsourcing to seek innovative strategies to optimise PrEP access by increasing the uptake and effective use of PrEP. This study describes the experiences of crowdsourcing open calls in Australia, the Philippines, Thailand and China.
Methods: Four crowdsourcing open calls were conducted between 2021-2023 in Australia, the Philippines, Thailand and China. All open calls entailed: 1) problem identification; 2) committee formation with local groups; 3) community engagement for idea submission (e.g., texts, posters, pitches); 4) evaluation of submissions; 5) awarding incentives to finalists; and 6) solution dissemination via web and social media. We reported the number of total and high-quality submissions. We also identified themes across countries.
Results: The Australian, Filipino, Thai and Chinese teams received 9, 22, 9 and 19 eligible submissions, respectively. A total of 3, 10, 7 and 8 submissions had a mean score of 6/10 or greater. Three common solutions emerged across all the finalist ideas: enhanced service access, optimising promotional campaigns, and person-centred promotional materials. The winning ideas from the Australian, Filipino, Thai and Chinese teams were an anonymous online PrEP service, a printed ready-to-wear garment to create awareness about PrEP, PrEP and HIV self-testing kit dispensing kiosks and a poster on PrEP effectiveness, respectively.
Conclusions: Crowdsourcing was a promising and versatile tool for developing PrEP strategies in the Asia-Pacific region. Further evaluations via clinical trials can bridge the gap between idea generation and implementation, creating the empirical evidence that is pivotal for the policy adoption of these innovations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079911 | PMC |
http://dx.doi.org/10.1186/s12879-025-11065-4 | DOI Listing |
Blood Cell Ther
August 2025
Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
[This corrects the article DOI: 10.31547/bct-2024-020.].
View Article and Find Full Text PDFLancet Reg Health West Pac
August 2025
Global HIV, Hepatitis and STI Programmes, World Health Organization (WHO), Geneva, Switzerland.
Background: The global spread of antimicrobial resistance (AMR) in threatens empiric single-dose gonorrhoea treatment. Enhanced global AMR surveillance is imperative. We report i) gonococcal antimicrobial susceptibility and resistance data from 2023 in the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (WHO EGASP) in the WHO Western Pacific Region (Cambodia, the Philippines, Viet Nam), Southeast Asian Region (Indonesia, Thailand), and African Region (Malawi, South Africa, Uganda, Zimbabwe), and ii) metadata of the gonorrhoea patients.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
September 2025
Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital and the University of Hong Kong, China.
Title: Can Radiotherapy Quality Assurance (RT QA) improve nasopharyngeal cancer (NPC) outcomes in low- and middle-income countries (LMICs) -Reporting phase 2 of a prospective International Atomic Energy Agency (IAEA) study (E33039).
Background: Most of new NPC cases occur in LMICs, but these patients experience poorer survival than new NPC cases in high income countries. This study seeks to determine whether a radiotherapy quality assurance (RT QA) programme can improve NPC patient outcomes in LMICs.
HPB (Oxford)
August 2025
Mater Hospital Brisbane, South Brisbane, Queensland, Australia.
Background: The rise in malignant hepatopancreatobiliary tumors disproportionately affects low- and middle-income countries (LMICs) due to systemic challenges. In 2023, the International Hepatopancreatobiliary Association (IHPBA) launched a relationship-building initiative to mitigate outcome disparities by increasing capacity and quality. This study aimed to understand the dynamics and value of such collaborations.
View Article and Find Full Text PDFJ Hepatol
September 2025
Hepatitis B Foundation & Loma Linda University, USA. Electronic address: